Aligos Therapeutics (ALGS) P/E (2020 - 2026)
Aligos Therapeutics (ALGS) P/E from Dec 31, 2020 to Jul 20, 2026. The TTM Aligos Therapeutics (ALGS) P/E is -0.36. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aligos Therapeutics (ALGS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.36 | -85.01% |
| 2025 | -2.41 | +123.28% |
| 2024 | -1.08 | +206.80% |
| 2023 | -0.35 | -3.54% |
| 2022 | -0.36 | -90.29% |
| 2021 | -3.75 | -87.76% |
| 2020 | -30.62 | N/A |
Comparison Aligos Therapeutics (ALGS) P/E with competitors
Aligos Therapeutics (ALGS) P/E is -0.36.